EN
HU
ES
IT
Chaga mushroom has a long history of traditional use and scientific research, including substantial clinical study efforts. In the 1950s, large clinical trials involving over 500,000 participants and more than 3,000 experiments were conducted to investigate adaptogenic substances. Chaga was identified as one of the most powerful adaptogens studied and was widely used to enhance mental and physical performance among soldiers, astronauts, and scientists.
Chaga was officially recognized as a remedy in 1955, being used especially for gastrointestinal and liver diseases, as well as a support in oncological treatments. This mushroom was present in traditional medicine since the 16th century, and in the 20th century Chaga-based extracts were created, later integrated into various therapeutic regimens.
Chaga mushroom (Inonotus obliquus) has shown promising benefits in laboratory and animal studies, with emerging clinical research supporting its uses.
Antioxidant and Anti-Inflammatory Effects
Chaga polysaccharides possess strong antioxidant activity measured in vitro, reducing oxidative stress and protecting cells. Animal models have confirmed anti-inflammatory effects, including reductions in cytokines and free radicals, which could help with disorders driven by inflammation.
Cancer Prevention and Support
Multiple preclinical studies found Chaga extracts inhibited the proliferation of oral, lung, liver, sarcoma, breast, prostate, and colon cancer cells by triggering apoptosis (cell death) and arresting tumor growth.
One animal study reported a 60% tumor reduction in mice supplemented with Chaga.
Blood Sugar, Cholesterol, and Immune Regulation
Preclinical studies indicated Chaga may reduce blood sugar by up to 31% in diabetic animal models, and act as an immune modulator by balancing cytokines and supporting white blood cell function.
Chaga extracts have also decreased LDL “bad” cholesterol and improved lipid profiles in animal models, suggesting possible cardiovascular benefits.
Antiviral Activity
Chaga contains compounds, such as betulinic acid and mycosterols, that inhibit the replication of viruses like hepatitis C, HIV, herpes simplex, and influenza in cell and animal studies.
Provita Nutrition has developed the product Chaga C-Max, a potent 5:1 hydroalcoholic extract to capture the therapeutic components of this unique mushroom.